Mend Raises $15 Million to Ensure Improved Healing for Surgical Patients Through Continuity Treatment with Nutrapharma – AlleyWatch

After surgery, acute wounds take about a month to heal, but full recovery can take up to a year, depending on the severity and type of injury. Giving your body the proper healing energy through hydration, diet, activity, rest, and proper wound care all contribute to the healing journey. mend provides a complete digital platform combined with a range of nutritional medicines to accelerate healing and patient compliance. Wellness supplements are natural, independently tested, non-GMO, gluten-free, and contain highly bioavailable ingredients formulated for acute care. The company’s products include “restoration and recovery” to promote healing of bones, wounds and tissues; “joint replacement” to prevent muscle atrophy after joint surgery; “cosmetics” to improve post-operative beauty; We offer special products such as ‘ bundle. Additionally, Mend offers several preventive and maintenance options such as muscle weakness and glycemic control. Complementing Nutrapharma’s selection is Upraid, the company’s virtual care platform touted as a digital healing platform for patients undergoing surgery. Physicians and their clinics can extend comprehensive care to post-surgical patients’ homes through a continuous care team, nutrition programs, and patient progress tracking to increase engagement, promote adherence, and reduce barriers. can be eliminated and provide continuity of care.

alley watch We spoke with the co-founder and CEO of Mend Esaiah Said To learn more about the business, the company’s strategic plans, the latest funding round that brought the company’s total funding to $29.6 million, and more…

Who are the investors and how much did you raise?

This is a $15 million Series A round, led by S2G Ventures And joined a syndicate of VCs including: iSelect Fund, Touchdown Ventures, Colorcon Ventures, Alumni Ventures, Keen Growth Capital, others. We are very proud of the strength of our syndicate and the alignment of our mission with our investors.

What products or services does Mend offer?

mend^TMs operates at the intersection of Nutrapharma, Food as Medicine and Digital Behavioral Health. We are leveraging these tools to improve acute care, which is under great stress due to staffing shortages, burnout, margin compression, and other pressures. In short, we use clinically proven solutions to expand and improve the level of care provided to patients in surgical and other acute care settings.

What inspired you to start Mend?

With many illnesses in the family (e.g. mother with cancer, older brother threatening life after falling down Carterskill Falls), the founding team realized gaps in acute care delivery. First, care was virtually non-existent outside the walls of hospitals, and second, acute care opportunities to position patients for transformation were missed.

How is mend different?

From clinically proven Nutrapharma (a new class of natural medicines) to medically tailored diets to digitally enabled care navigation with in-house clinical experts, the company that brings together the holistic solution we offer is the market does not exist in nurse and nutritionist.This is a paradigm shift in medicine and treatment^TMs Leading on the front line.

What markets is Mend targeting and how big is it?

The company is currently focused on orthopedics, but is designing pathways of care in other indications such as oncology. Orthopedic surgery alone is a very large market, with approximately 7 million surgeries performed annually in the United States alone. Musculoskeletal injuries account for 77% of his medical visits related to injuries, and this condition costs us about $200 billion annually. We spend billions of dollars as a result of poor outcomes and readmissions, and acute care pressures will jeopardize quality in the future.

What is your business model?

We have a variety of ways to generate revenue from cash payments made by consumers, hospitals that purchase our solutions, and payers that cover our solutions. We are a consumer and B2B2C hybrid company.

How are you preparing for a potential economic slowdown?

We’re going to be disciplined about cash and runway management. Luckily, we have clients on contract who don’t necessarily need new business and are focused on execution. I will ask the team to manage the funds efficiently and generate as much leverage as possible to maximize the runway.

What was the fundraising process like?

Fundraising in this environment is extremely difficult, but we have been successful thanks to our market traction and unique business model. Having a strong lead investor is always helpful. We are very grateful to have a talented investor like S2G leading the round. Our investors have put in a lot of effort into us, which has inspired trust both externally and internally. We know a lot of very smart people have been in our business and we got a passing grade.

What was the biggest challenge you faced while fundraising?

Our fundraising was relatively smooth, but given the environment we were in, there was an even greater emphasis on diligence. We had to be patient with the process and create proof points whenever requested. Also, his SVB occurred mid-raise, which slowed down the process.

What factors about your business made investors write checks?

Market traction and business model. It helps a lot if investors can call real customers and hear the impact their solutions are having. And our business model and defenses are attractive to investors. We build unique things that are hard to replicate.

What milestones do you plan to achieve in the next six months?

It’s all about performing to the contract and extending clients who are already ready to extend their use of the solution. We’re going to burn midnight oil and go crazy for executions. If we do well in the next six months, we will be very well positioned in 2024.

What advice would you give to New York companies that haven’t recapitalized their banks?

It’s easy to get bloated, so I always check my books for unnecessary spending. Stay in the build-your-own spirit and get the most out of your $1. Get the evidence your investors want – easier said than done, but you gotta stick, keep fighting, stay resilient.

It’s easy to get bloated, so I always check my books for unnecessary spending. Stay in the build-your-own spirit and get the most out of your $1. Get the evidence your investors want – easier said than done, but you gotta stick, keep fighting, stay resilient.

Where do you see the company going in the short term?

My focus is on fulfillment and delivery to existing contracts and clients. If we do it well, our company knows no bounds. A few more pieces are in place to set us up for a very big year in 2024. It is expected to inject more capital to accelerate growth.

What are your favorite summer destinations in and around the city?

We recently purchased a location on the North Fork and love it there. For those who haven’t visited, it’s worth checking out. Vineyards, beaches, organic farms and an idyllic setting. This is a really special place and you can get there in just over an hour without traffic. I would love to join you for a rosé in the vineyards.

---

You’re just seconds away from joining Tech!’s hottest list.

sign up today

---